Celgene (CELG) Announces POMALYST Label Update Approved by FDA
Tweet Send to a Friend
Celgene Corporation(NASDAQ: CELG) today announced it has fulfilled the accelerated approval requirements for POMALYST® (pomalidomide) based on results from MM-003 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE